BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 31586572)

  • 1. Bloodstream infections in neutropenic patients with haematological malignancies.
    Carvalho AS; Lagana D; Catford J; Shaw D; Bak N
    Infect Dis Health; 2020 Feb; 25(1):22-29. PubMed ID: 31586572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and microbiological characteristics of bloodstream infections among patients with haematological malignancies with and without neutropenia at a medical centre in northern Taiwan, 2008-2013.
    Chen CY; Tien FM; Sheng WH; Huang SY; Yao M; Tang JL; Tsay W; Tien HF; Hsueh PR
    Int J Antimicrob Agents; 2017 Mar; 49(3):272-281. PubMed ID: 28109554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bloodstream infections in neutropenic and non-neutropenic patients with haematological malignancies: epidemiological trends and clinical outcomes in Queensland, Australia over the last 20 years.
    Peri AM; Edwards F; Henden A; Harris PNA; Chatfield MD; Paterson DL; Laupland KB
    Clin Exp Med; 2023 Dec; 23(8):4563-4573. PubMed ID: 37815735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissecting bloodstream infections in febrile neutropenic patients with hematological malignancies, a decade-long single center retrospective observational study (2009-2019).
    El Omri H; Padmanabhan R; Taha RY; Kassem N; Elsabah H; Ellahie AY; Santimano AJJ; Al-Maslamani MA; Omrani AS; Elomri A; El Omri A
    J Infect Public Health; 2024 Jan; 17(1):152-162. PubMed ID: 38029491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence, risk factors, and outcome of bloodstream infections during the pre-engraftment phase in 521 allogeneic hematopoietic stem cell transplantations.
    Blennow O; Ljungman P; Sparrelid E; Mattsson J; Remberger M
    Transpl Infect Dis; 2014 Feb; 16(1):106-14. PubMed ID: 24372809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changing aetiology, clinical features, antimicrobial resistance, and outcomes of bloodstream infection in neutropenic cancer patients.
    Gudiol C; Bodro M; Simonetti A; Tubau F; González-Barca E; Cisnal M; Domingo-Domenech E; Jiménez L; Carratalà J
    Clin Microbiol Infect; 2013 May; 19(5):474-9. PubMed ID: 22524597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early versus late onset bloodstream infection during neutropenia after high-dose chemotherapy for hematologic malignancy.
    Widmer AF; Kern WV; Roth JA; Dettenkofer M; Goetting T; Bertz H; Theilacker C;
    Infection; 2019 Oct; 47(5):837-845. PubMed ID: 31187401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends and antimicrobial resistance of pathogens causing bloodstream infections among febrile neutropenic adults with hematological malignancy.
    Chen CY; Tang JL; Hsueh PR; Yao M; Huang SY; Chen YC; Chen YC; Shen MC; Wang CH; Tsai W; Chang SC; Tien HF; Luh KT
    J Formos Med Assoc; 2004 Jul; 103(7):526-32. PubMed ID: 15318274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bloodstream infections in neutropenic patients with cancer: differences between patients with haematological malignancies and solid tumours.
    Marin M; Gudiol C; Ardanuy C; Garcia-Vidal C; Calvo M; Arnan M; Carratalà J
    J Infect; 2014 Nov; 69(5):417-23. PubMed ID: 24960295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bloodstream infections in haematological cancer patients colonized by multidrug-resistant bacteria.
    Cattaneo C; Di Blasi R; Skert C; Candoni A; Martino B; Di Renzo N; Delia M; Ballanti S; Marchesi F; Mancini V; Orciuolo E; Cesaro S; Prezioso L; Fanci R; Nadali G; Chierichini A; Facchini L; Picardi M; Malagola M; Orlando V; Trecarichi EM; Tumbarello M; Aversa F; Rossi G; Pagano L;
    Ann Hematol; 2018 Sep; 97(9):1717-1726. PubMed ID: 29705860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology of bloodstream infections in patients with haematological malignancies with and without neutropenia.
    Chen CY; Tsay W; Tang JL; Tien HF; Chen YC; Chang SC; Hsueh PR
    Epidemiol Infect; 2010 Jul; 138(7):1044-51. PubMed ID: 19941686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intestinal colonisation and blood stream infections due to vancomycin-resistant enterococci (VRE) and extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBLE) in patients with haematological and oncological malignancies.
    Liss BJ; Vehreschild JJ; Cornely OA; Hallek M; Fätkenheuer G; Wisplinghoff H; Seifert H; Vehreschild MJ
    Infection; 2012 Dec; 40(6):613-9. PubMed ID: 22665143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of vancomycin resistance on mortality in neutropenic patients with enterococcal bloodstream infection: a retrospective study.
    Cho SY; Lee DG; Choi SM; Kwon JC; Kim SH; Choi JK; Park SH; Park YJ; Choi JH; Yoo JH
    BMC Infect Dis; 2013 Oct; 13():504. PubMed ID: 24164924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology and emerging resistance in bacterial bloodstream infections in patients with hematologic malignancies.
    Kara Ö; Zarakolu P; Aşçioğlu S; Etgül S; Uz B; Büyükaşik Y; Akova M
    Infect Dis (Lond); 2015; 47(10):686-93. PubMed ID: 26024284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study.
    Wisplinghoff H; Bischoff T; Tallent SM; Seifert H; Wenzel RP; Edmond MB
    Clin Infect Dis; 2004 Aug; 39(3):309-17. PubMed ID: 15306996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Impact of Bacterial Biofilms on End-Organ Disease and Mortality in Patients with Hematologic Malignancies Developing a Bloodstream Infection.
    Di Domenico EG; Marchesi F; Cavallo I; Toma L; Sivori F; Papa E; Spadea A; Cafarella G; Terrenato I; Prignano G; Pimpinelli F; Mastrofrancesco A; D'Agosto G; Trento E; Morrone A; Mengarelli A; Ensoli F
    Microbiol Spectr; 2021 Sep; 9(1):e0055021. PubMed ID: 34406812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence of multidrug resistant acinetobacter blood stream infections in febrile neutropenia patients with haematological cancers and bone marrow failure syndromes.
    Sood P; Seth T; Kapil A; Sharma V; Dayama A; Sharma S; Kumar S; Singh AK; Mishra P; Mahapatra M
    J Indian Med Assoc; 2012 Jul; 110(7):439-44. PubMed ID: 23520666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real-Life Use of Ceftolozane/Tazobactam for the Treatment of Bloodstream Infection Due to Pseudomonas aeruginosa in Neutropenic Hematologic Patients: a Matched Control Study (ZENITH Study).
    Bergas A; Albasanz-Puig A; Fernández-Cruz A; Machado M; Novo A; van Duin D; Garcia-Vidal C; Hakki M; Ruiz-Camps I; Del Pozo JL; Oltolini C; DeVoe C; Drgona L; Gasch O; Mikulska M; Martín-Dávila P; Peghin M; Vázquez L; Laporte-Amargós J; Durà-Miralles X; Pallarès N; González-Barca E; Álvarez-Uría A; Puerta-Alcalde P; Aguilar-Company J; Carmona-Torre F; Clerici TD; Doernberg SB; Petrikova L; Capilla S; Magnasco L; Fortún J; Castaldo N; Carratalà J; Gudiol C
    Microbiol Spectr; 2022 Jun; 10(3):e0229221. PubMed ID: 35475683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bloodstream infections in patients with solid tumors: epidemiology, antibiotic therapy, and outcomes in 528 episodes in a single cancer center.
    Marín M; Gudiol C; Garcia-Vidal C; Ardanuy C; Carratalà J
    Medicine (Baltimore); 2014 May; 93(3):143-149. PubMed ID: 24797169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Third generation cephalosporin resistant Enterobacteriaceae and multidrug resistant gram-negative bacteria causing bacteremia in febrile neutropenia adult cancer patients in Lebanon, broad spectrum antibiotics use as a major risk factor, and correlation with poor prognosis.
    Moghnieh R; Estaitieh N; Mugharbil A; Jisr T; Abdallah DI; Ziade F; Sinno L; Ibrahim A
    Front Cell Infect Microbiol; 2015; 5():11. PubMed ID: 25729741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.